Reading the Water: Navigating What Matters in Regulatory and Quality

Sam Murray, Head of Regulatory & Quality • May 21, 2026

Right Sizing Your Quality System

Many small companies start their quality system the same way. They buy an SOP pack. Or they sign up for a popular eQMS marketed to startups and turn on the starter set that comes with it. It feels efficient. It feels like progress.


Much of the time, it creates a different problem.


Those systems are usually built to work for everyone. That means they rarely fit anyone especially well. For a small company, they are often too complex. For a larger company with a more complicated product, they may not go far enough.


The bigger issue is that most companies using those systems are not in a position to tell the difference. They do not know whether a given procedure reflects an actual requirement or just one company’s preferred way of meeting that requirement.


I saw this often when I was in the FDA. Some of the companies with the most resources still ended up in trouble, not because they ignored quality, but because they built systems they could not actually run.


One example that stuck with me was training. Under the old QSR, the training requirement itself was less than a paragraph. This company turned it into a nine-page procedure and built it into a complex custom LMS. On paper, it looked robust. In practice, it did the opposite of what it was supposed to do.

When I brought in the manager and asked a basic question, who is qualified to perform which job, she could not answer it clearly. She could not tell me what record she used to confirm that an employee was qualified. At the time, we could not even say with confidence whether the person running release QC testing was actually qualified to run that test.


That is the problem with overbuilt quality systems. They create activity without creating control.


A lot of young companies assume the safest thing to do is write more. More SOPs. More approvals. More workflow. More software.


That is not the same thing as having a stronger quality system.


A good quality system should do three things. It should meet the requirements. It should fit the company. It should be something the team can actually use and maintain.


This is where founders usually need help. Not because they are incapable of running quality, but because they need someone to separate what is required from one possible way of meeting the requirement. There is usually more than one acceptable way to build a compliant system.

The right quality system is not the biggest one. It is the one the company can live with, scale with, and defend when it matters.


You do not need the biggest boat in the marina. You need one you can actually run, maintain, and trust when the water gets rough.


Sam Murray, Head of Quality PRIA

Sam Murray

Head of Regulatory & Quality


Click the Icon below to share this with your network

Cleared for takeoff: Insights from a Medtech First Officer
By Suzy Engwall May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
By Sam Murray, PRIA May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality  - Sam Murray, PRIA
By Sam Murray, Head of Regulatory & Quality May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program
April 24, 2026
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
MedTech Clinical Evidence Strategy
By PRIA Healthcare April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare welcomes Sam Murray as Head of Regulatory and Quality Services
March 10, 2026
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.
PRIA a strategic and execution partner for reimbursement and market access
By Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, Market Access and Corporate Development February 23, 2026
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's H2 Newsletter - PRIA Pages
By Nancy Bax December 23, 2025
PRIA's Second Quarter in Review
PRIA is proud to support LSI in 2026
By Nancy Bax November 6, 2025
Continuing and Strengthening our Relationship with a Vital Industry Event
PRIA helps clients navigate the challenging MedTech market access landscape
By Nancy Bax October 21, 2025
A leader in Reimbursement & Market Access Services, PRIA has followed developments on WISeR. Here is our summary of the new CMS Provider & Supplier Operational Guide
Behind the Strategy - An Expert's Perspective by Tonya Dowd, PRIA
By Tonya Dowd, MPH, EVP of RHEMA and Corporate Development August 5, 2025
US Reimbursement Policy in Flux
By PRIA Healthcare August 1, 2025
Prior Authorization is Coming to Fee-for-Service Medicare -- What You Need to Know About CMS's Proposed WISeR Model -- a webinar from PRIA Healthcare